Dr. Simon Sumer explains how AI‑driven protein design is shortening development cycles, improving screening efficiency, and ...
Hosted on MSN
AI is reshaping GPCR drug discovery
Artificial intelligence is accelerating breakthroughs in G protein-coupled receptor (GPCR) research, a key area for developing new medicines. From predicting complex receptor structures to screening ...
Researchers have developed a new artificial intelligence (AI) model that can more accurately predict how proteins interact ...
Multiple research fronts saw major advances on April 24, 2026, with AI models driving new capabilities in protein interaction prediction, automated protein design, and earthquake engineering ...
Researchers from the National Institute for Physiological Sciences, Nagoya City University, and Tokyo Metropolitan Institute ...
This review examines how high-throughput proteomics is expanding precision medicine by improving biomarker discovery, disease ...
Okazaki, Japan, 22 April 2026 – Potassium ions (K⁺) are essential for all cells and living organisms. Scientists have long believed that K⁺ merely ...
For years, AI drug discovery has been judged on benchmark performance. Now, a set of studies shows what happens when those ...
Recent advances in high-throughput proteomics enable the measurement of thousands of proteins simultaneously, offering unprecedented insight into human health and disease. A new review summarizes how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results